Current Offerings

  • Alzheimer's

    Neurotez, Inc.

    Alzheimer's

    Neurotez, Inc.

    minimum raise:
    $4,000,000

    Developing a recombinant human Leptin therapy for Alzheimer's Disease and as a preventative for those at risk...

    More

  • Kidney Disease

    GLG Pharma, LLC

    Kidney Disease

    GLG Pharma, LLC

    minimum raise:
    $3,000,000

    Combine advanced diagnostics and proprietary drugs to target ADPKD and p-STAT3 mediated cancers...

    Coming Soon...

  • Epilepsy

    Insero Health, Inc

    Epilepsy

    Insero Health, Inc

    minimum raise:
    $4,000,000

    Develop therapeutics from natural products to address unmet needs in neurological diseases like epilepsy...

    Coming Soon...

  • Infectious Disease

    EntraTympanic, LLC

    Infectious Disease

    EntraTympanic, LLC

    minimum raise:
    $3,500,000

    Device allows safe, in-office treatment of middle ear infections that affects 28M people in the US every year...

    Coming Soon...

  • Genomics

    Genomic Expression, Inc.

    Genomics

    Genomic Expression, Inc.

    minimum raise:
    $1,000,000

    Develop Next Generation diagnostics to guide health professionals to more individually effective patient...

    Coming Soon...

  • Cardiovascular

    AblaCor Medical Corp

    Cardiovascular

    AblaCor Medical Corporation

    minimum raise:
    $1,000,000

    Proprietary ablation catheter technology offers more effective treatment of atrial fibrillation (AF)...

    Coming Soon...

  • Cancer

    NeOnc Technologies, Inc.

    Cancer

    NeOnc Technologies, Inc.

    minimum raise:
    $1,000,000

    Developing a therapeutic using perillyl alcohol for intranasal treatment of brain-related and respiratory cancers...

    Coming Soon...

Invest in Innovative Healthcare and Life Science Companies
Poliwogg tadpole

see how it works

  • Having served as a Governor and as the Secretary of the U.S. Department of Health and Human Services, I know firsthand the challenges our country faces in creating a better health future for all Americans. Poliwogg's innovative approach to expanding healthcare investment opportunities for all our citizens is crucial to bringing the private sector and private capital to bear on the largest and most important part of our economy.

    Tommy G. Thompson Chairman of the Poliwogg Board
    Former Governor of Wisconsin and Former Secretary of Health and Human Services

  • Having worked with hundreds of start-up healthcare companies over the past 30 years, I've been saddened by how limited and often counter-productive our healthcare investment models have been in spite of the unprecedented opportunities we currently have before us for discovery in the life sciences. As a result, I am thrilled to help Poliwogg disrupt those antiquated models with a whole portfolio of tools for 21st century healthcare investing. And I look forward to seeing Poliwogg catalyze healthcare innovation on a whole new scale for decades to come.

    Marcia A. Kean Chairman, Strategic Initiatives / Feinstein Kean Healthcare

  • One of the great opportunities of the interconnected world is the chance to direct capital more effectively toward investment in innovation that achieves social good. Health care has been crying out for this type of innovation for years. Poliwogg provides a trustworthy platform to begin this important transformation to see health as an asset instead of a cost.

    Chris Kelly Entrepreneur / Former Chief Privacy Officer, Facebook

  • Poliwogg's platform and set of products that will allow individuals to invest in health. We at the Epilepsy Foundation think Poliwogg will help address a critical gap in funding for early stage companies and help advance promising therapies down the path to helping people. We are excited to partner with Poliwogg as we work together with our community to accelerate innovation to stop seizures, side-effects and lost lives from epilepsy.

    Warren Lammert Chairman, Epilepsy Foundation / Chairman, Granite Point Capital

  • The transformation underway in American healthcare represents a tectonic shift in an industrial sector accounting for nearly 20% of the U.S. economy. Poliwogg’s commitment is to serve investors with new ways to participate early on in the decade of explosive growth, innovation and change that lies ahead.

    Ernie Ludy Founder, Thomson Medstat

  • Poliwogg addresses a large unmet need in the innovation value chain – the funding of bold, frugal, and transformational opportunities. That's Poliwogg's sweet spot. And it is creating instruments to allow investors to access that market while mitigating the risks involved. It's bound to create substantial amounts of value.

    Bernard Munos Founder, InnoThink Center for Research in Biomedical Innovation

  • The healthcare industry and the ways we fund it are rapidly evolving. New sources of capital from individual investors are playing a more important role alongside traditional institutional investors and venture capitalists. Poliwogg enables these investors to participate in funding the industry in a meaningful and efficient way. I expect Poliwogg and its network to play an important role in advancing life sciences companies and, thus, to help bring important new therapies to patients.

    Dennis Purcell Senior Managing Director of Aisling Capital

Bloomberg-Businessweek 0
BusinessWire 0
CNBC
CrowdfundInsider 0
EBIlogo 0
Fierce-Biotech
GEN 0
MoneyNews
PRWeb 0
The-IN-VIVO-Blog 0

Important Disclosure: Poliwogg.com is a website owned by Poliwogg Services, LLC ("Poliwogg"). Poliwogg is not a registered broker-dealer. Private investment marketing and other broker-dealer services are offered through SDDCO Brokerage Advisors, LLC Member: FINRA/SIPC ("SDDCO-BA"), a registered Broker/Dealer. Poliwogg and its affiliates are independent and unaffiliated with SDDCO-BA. Where investment services are offered by Poliwogg-associated persons such offers are made in their capacities as registered representatives of SDDCO-BA. By accessing this website and any pages on this site, you have agreed to be bound by Poliwogg's Terms of Use and Privacy Policy. Poliwogg does not provide investment, legal or tax advice. No communication, through this website or in any other medium, should be construed as a recommendation by Poliwogg of any securities offering on or off this investment platform. Investments on this site are intended only for accredited investors who are familiar with and are willing to accept the high risk associated with investing in privately held companies and early stage ventures. These investments are not publicly traded and are illiquid securities involving an indefinite holding period. These investments are intended for investors who do not have a need for liquidity and can afford to lose their entire investment. To the fullest extent permissible by law, neither Poliwogg nor any of its directors, officers, employees, representatives, affiliates or agents shall have any liability whatsoever arising out of any error or incompleteness of fact or opinion in the presentation or publication of the materials and communication herein.